Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
Clinical trial NCT00471094 · COMPLETED
Trial details
- NCT number
- NCT00471094
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2007-10-01
- Enrollment
- 831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.